Platinum-based pharmaceuticals function by binding to DNAs to interfere with their replication, thereby preventing the division and growth of tumor cells.

As a second-generation platinum-based pharmaceutical, nedaplatin is more soluble in water and appears to be less toxic to kidney and digestive system, and therefore more suitable for elderly patients as well as patients with renal insufficiency.